Phase I study of dasatinib in combination with capecitabine, oxaliplatin, and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

被引：2
|
作者：
Starodub, A.
Cohn, A. L.
Arrowood, C.
Haley, S.
Morse, M.
Uronis, H. E.
Blobe, G. C.
Hsu, S. D.
Zafar, Y.
Hurwitz, H.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer
    Petrioli, Roberto
    Francini, Edoardo
    Cherri, Sara
    Torre, Pamela
    Fiaschi, Anna Ida
    Miano, Salvatora Tindara
    Marrelli, Daniele
    Rovello, Franco
    Francini, Guido
    CLINICAL COLORECTAL CANCER, 2018, 17 (04) : E663 - E669
  • [22] A phase ii study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer
    Bendell, J.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Vaccaro, G.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    ANNALS OF ONCOLOGY, 2006, 17 : 67 - 67
  • [23] Phase II study of oxaliplatin, capecitabine, and irinotecan (OCI) in patients (pts) with previously untreated advanced colorectal cancer
    Pavia, OA
    Cangiano, J
    Crisostomo, R
    Caceres, W
    Barranco, E
    Wright, M
    Antonia, T
    Antonia, S
    Sullivan, D
    Garrett, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 307S - 307S
  • [24] Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC).
    Meyerhardt, JA
    Xhu, A
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Michelini, A
    Vincitore, M
    Thomas, A
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 265S - 265S
  • [25] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sym, Sun Jin
    Ryu, Min-Hee
    Kang, Hye Jin
    Lee, Sung Sook
    Chang, Heung-Moon
    Lee, Jae Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 373 - 380
  • [26] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sun Jin Sym
    Min-Hee Ryu
    Hye Jin Kang
    Sung Sook Lee
    Heung-Moon Chang
    Jae Lyun Lee
    Tae Won Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 373 - 380
  • [27] Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
    Mohamad Farid
    Balram Chowbay
    Xiangai Chen
    Sze Huey Tan
    Saminathan Ramasamy
    Wen Hsin Koo
    Han Chong Toh
    Su Pin Choo
    Simon Yew Kuang Ong
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 141 - 150
  • [28] Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
    Farid, Mohamad
    Chowbay, Balram
    Chen, Xiangai
    Tan, Sze Huey
    Ramasamy, Saminathan
    Koo, Wen Hsin
    Toh, Han Chong
    Choo, Su Pin
    Ong, Simon Yew Kuang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 141 - 150
  • [29] Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer
    Kozuch, Peter
    Malamud, Steve
    Wasserman, Carrie
    Homel, Peter
    Mirzoyev, Takhir
    Grossbard, Michael
    CLINICAL COLORECTAL CANCER, 2009, 8 (01) : 38 - 42
  • [30] Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer
    Lai, Lily L.
    Chiu, Ken
    Lim, Dean
    Chao, Joseph
    Frankel, Paul Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345